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ABSTRACT. Magnetic nanoparticles are important tools for biomedicine, where they serve as 
versatile multifunctional instruments for a wide range of applications. Among these 
applications, magnetic hyperthermia is of special interest for the destruction of tumors and 
triggering of drug delivery. However, many applications of magnetic nanoparticles require high 
quality magnetic nanoparticles displaying high specific absorption rates, which remains a 
challenge today. We report here the functionalization and stabilization in aqueous media of 
highly magnetic 15 nm iron carbide nanoparticles featuring excellent heating power through 
magnetic induction. The challenge of achieving water solubility and colloidal stability was 
addressed by designing and using specific dopamine-based ligands. The resulting nanoparticles 
were completely stable for several months in water, phosphate, phosphate-buffered saline and 
serum-containing media. Iron carbide nanoparticles displayed high specific absorption rates 
(SAR) in water and viscous media (water/glycerol mixtures), even after extended exposition to 
water and oxygen (SAR up to. 1000 W·g-1 in water at 100 kHz, 47 mT). The cytotoxicity and 
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cellular uptake of iron carbide nanoparticles could be easily tuned and were highly dependent 
on the chemical structure of the ligands used.  
KEY WORDS. nanoparticles – iron carbide – magnetic hyperthermia – functionalization – 
biocompatibility 
Magnetic nanoparticles (NPs) are of strategic interest for several biomedical applications such 
as magnetic resonance imaging,1-3 magnetic hyperthermia1,4-6 and drug delivery.1,3,6 When 
exposed to an alternating magnetic field, suitable magnetic NPs undergo energy losses, thus 
producing heat. This phenomenon, called magnetic hyperthermia, is widely applied 
biomedically to destroy or weaken tumors,5 trigger drug delivery6 or improve drug efficacy.6 
For magnetic hyperthermia to be efficient, however, magnetic NPs must be designed to 
maximize energy losses and thus the production of heat. The ability of NPs to heat through 
magnetic induction is commonly expressed by their specific absorption rate (SAR), and the 
objective is to reach high SAR at frequencies and amplitudes harmless for healthy tissues7,8 
(typically 100 kHz, 20 mT). Substantial effort has been dedicated to the synthesis of water 
stable and biocompatible NPs displaying high SARs. Given these requirements, iron-based 
nanoparticles appear to be promising candidates.9 Among them, iron oxide nanoparticles 
(IONPs) have been extensively studied. As a result, a significant number of synthetic 
procedures allowing the production of tunable iron oxide nanoparticles (size, shape, 
composition, etc.) are available.10,11 While commercially available IONPs generally display 
poor hyperthermia properties, very good SARs were reported for complex IONPs such as 
magnetite bacterial magnetosomes,12 maghemite nanoflowers13 or maghemite nanocubes.14,15 
Despite their promising properties, these complex IONPs are not easily synthesized and exhibit 
a low saturation magnetization (70-80 A.m2.kg-1 in the best cases). Iron has the highest 
saturation magnetization (210 A.m2.kg-1) among all elements, and Fe(0) NPs were shown to 
have very good SARs in organic solvents.16,17 Unfortunately, in the presence of oxygen or 
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water, zero-valent iron NPs undergo very fast oxidation that dramatically affects their magnetic 
properties, reducing their utility as hyperthermic agents.  
Iron carbide NPs provide a potential compromise between high saturation magnetization and 
stability in biological media. Several studies evidenced their potential for applications including 
magnetic hyperthermia,18-20 magnetic resonance imaging,21 catalysis.19,20,22-24 We recently 
reported the synthesis of specific Fe2.2C ICNPs displaying exceptional SAR for applications in 
CO2 hydrogenation.
20 We report here the use of dopamine-based ligands to functionalize these 
ICNP structures and stabilize them efficiently in aqueous and biological media. Even after 
extended exposure to water and oxygen, these ICNPs present SARs higher than the ones of 
Fe(0) nanoparticles. The critical influence of the ligand structural design regarding the 
cytotoxicity and cellular-uptake of these ICNPs was also evidenced. 
RESULTS/DISCUSSION 
Monodisperse ICNPs (15 nm) were synthesized through the carbidization of preformed Fe(0) 
nanoparticles under CO/H2, following an approach previously described by our group (Figure 
S1).20,25 These nanoparticles displayed excellent hyperthermia properties, with specific 
absorption rates (SARs) far higher than any iron oxide or iron(0) nanoparticles. However, due 
to the fatty acid and amine ligands of the as-prepared ICNPs, these particles are dispersible only 
in organic solvents, and further surface modification was mandatory to provide solubility and 
colloidal stability in aqueous environment. This challenge was addressed by replacing the initial 
hydrophobic stabilizers by specifically designed dopamine-based ligands (Figure 1) through a 
ligand exchange reaction.  
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Figure 1: Dopamine-based ligand structural design. 
The ligand family was synthesized by adapting a previously described synthetic procedure26,27 
starting from the dopamine derivative (I), which contains a catechol moiety. This catechol 
moiety is known to bind strongly to iron-based nanoparticle surfaces,28 and especially to iron 
oxide. However, dopamine derivatives were also recently described as suitable ligands for the 
stabilization of iron carbide nanoparticles (Fe5C2) in water.
18,21,29  
The ligand structure contains a hydrophobic alkyl chain (II) which contributes to the 
stabilization of the NPs by fostering micelle-like hydrophobic assembly of the ligands. The 
tetraethylene glycol moiety (III) affords water solubility, biocompatibility and stability to the 
functionalized NPs. At the terminus, the function (IV) of the ligand can be easily modified to 
tune the behavior of the NPs in biological media. In a typical ligand exchange reaction, ICNPs 
(10 mg) were dispersed in a mixture of dichloromethane and methanol (5/1). The water-soluble 
ligand (50 mg, 5 mass equivalents compared to ICNPs) was added to the dispersion, followed 
by triethylamine (250 µL). The mixture was stirred overnight at room temperature. The work 
up of the reaction consisted of 3 washings with hexane followed by redispersion in water and 
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purification by dialysis for 48 h. The presence of the desired ligands on the surface of ICNPs 
was confirmed by LDI/MS experiments (Figure S2-6).27 In addition, thermo-gravimetric 
analysis of the ICNPs before and after the ligand exchange reaction was performed (Figure S7). 
The results showed that the characteristic signature of the long chain amine and acid ligands 
observed for as-synthesized ICNPs is missing in the case of water soluble ICNPs, and replaced 
by a signal attributed to the dopamine-based ligands. These observations indicate that the long 
chain amine and acid ligands were efficiently exchanged by the dopamine-derivatives during 
the ligand exchange reaction. This is in agreement with LDI-MS measurements, which did not 
evidence the presence of the initial hydrophobic ligands at the surface of the functionalized 
ICNPs (Figure S2-6). Taken together, these results suggest that the ICNPs are stabilized through 
the direct coordination of the dopamine-based ligands, rather than by their intercalation through 
hydrophobic interaction with remaining hexadecylamine and palmitic acid. 
The stability of ICNPs functionalized with different types of ligands was investigated in 
multiple aqueous media (de-ionized water, phosphate buffer 5 mM (PB), phosphate-buffered 
saline 150 mM (PBS) and media containing 10% bovine serum albumin (BSA) using dynamic 
light scattering (DLS) and transmission electron microscopy (TEM) analysis. Special interest 
was dedicated to the stability of ICNPs in PBS and serum media since their properties are closer 
to real biological conditions.  The multiple types of ligands tested – commercial or synthesized 
– are disclosed in Table 1, together with their ability to bring ICNPs solubility and stability in 
aqueous media. 
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Table 1. Summary of the ligands used to transfer ICNPs in aqueous media. aPB = Phosphate 
Buffer 5 mM; bPBS = Phosphate-Buffered Saline 150 mM; cSerum containing 10% Bovine 
Serum Albumin. (I) DOP-TEG-OH; (II) DOP-TEG-COOH; (III) DOP-TEG-TTMA; (IV) 
DOP-TEG-C6; (V) DOP-TEG-Zwitter. 
 
 
The first stability tests were performed with simple commercial ligands commonly used to 
stabilize magnetic NPs such as iron oxide in aqueous media.30-32 The results show that these 
ligands all fail to stabilize ICNPs in water, with the nanoparticles aggregating and precipitating 
in a few minutes. ICNPs thus require more advanced ligands than iron oxide NPs to be stable 
in water. The use of specifically synthesized dopamine-based ligands provided ICNPs with 
surprisingly good solubility and stability in all aqueous media studied. Among the five 
7 
 
dopamine-based ligands presented in this table, we will focus on three particular ligands 
displaying respectively anionic (DOP-TEG-COOH), cationic (DOP-TEG-C6) and zwitterionic 
functionality (DOP-TEG-Zwitter). 
For all three ligands, TEM analyses of the NPs before and after functionalization show that the 
NPs morphology is not affected by the ligand exchange or water exposure (Figure 2a and 2c). 
Interestingly, the stability of the functionalized ICNPs is such that they cannot be precipitated 
by magnet-assisted decantation. At suitable concentration, however, the solutions containing 
functionalized ICNPs exhibit a ferrofluid behavior (Figure 2d). According to DLS 
measurements, the ICNPs display very good colloidal stability in all types of aqueous media 
considered, with their hydrodynamic diameter remaining constant for more than one month 
(Figure 2e,g,i). While in all cases ICNPs appear to be individually stabilized in water, PB and 
PBS (DH ~ 15-20 nm), the hydrodynamic diameter of the particles in serum media is 
significantly larger (~ 90 nm). This increase in size is attributed to a partial aggregation of 
nanoparticles induced by the interactions between the ligands and the proteins of the serum, 
forming a protein corona shell.33 TEM analysis revealed the presence of ~ 90 nm assemblies, 
thus confirming this hypothesis (Figure S8). 
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Figure 2: (a,b) ICNPs in mesitylene, (c,d) functionalized ICNPs (DOP-TEG-C6 ligand) in 
water, similar results were obtained with the other two ligands. DLS analysis of functionalized 
ICNPs in aqueous media as a function of time and temperature: (e,f) functionalized with DOP-
TEG-C6; (g,h) functionalized with DOP-TEG-COOH; (i,j) functionalized with DOP-TEG-
Zwitter. PBS = Phosphate-Buffered Saline. 
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Interestingly, colloidal solutions containing functionalized ICNPs could be exposed to a wide 
range of temperatures without any aggregation or precipitation of the NPs (Figure 2f,h,j). The 
only exception was observed with ICNPs functionalized with DOP-TEG-Zwitter, with an 
obvious aggregation and precipitation of the NPs after exposure to temperatures higher than 
60°C. The effects of the exposure of ICNPs to water and air on their structural and magnetic 
properties were investigated by XRD, VSM, and specific absorption rate (SAR) measurements 
(Figure 3 and S8). 
 
Figure 3: Magnetic properties of ICNPs before (as synthesized) and after 4 months exposure 
to water and air (functionalized ICNPs, DOP-TEG-C6 ligand). (a) VSM analysis at 300 K, (b) 
SAR measurement at 100 kHz. For comparison reasons, the SAR of as-synthesized Fe(0) NPs 
of similar size is also given. 
XRD analysis evidences partial oxidation of the nanoparticles after a four-month exposure to 
water and air, but the pseudo-hexagonal Fe2.2C structure is still clearly visible (Figure S9). As 
a result of oxidation, VSM analysis (Figure 3a) shows that the saturation magnetization (90 
A.m2.kg-1) and the coercive field (32 mT) of ICNPs are significantly reduced as compared to 
starting nanoparticles (160 A.m2.kg-1, 102 mT respectively). Nevertheless, the SAR of these 
functionalized NPs in water remain high, reaching ca. 1000 W·g-1 at 47 mT, 100 kHz. Indeed, 
their magnetic heating properties even after partial oxidation are still better than those of 12.5 
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nm Fe(0) NPs synthesized and kept under oxygen- and water-free conditions (Figure 3b). Thus, 
despite a partial oxidation and modification of their magnetic properties, ICNPs maintain high 
SARs values after 4 months in water and under air, making them promising candidates for 
biomedical applications in which magnetic heating is required. 
Having a library of ligands displaying different functions and charges allows tuning of the 
cytotoxicity and cellular-uptake of the [ICNPs-Ligand] couple. The cytotoxicity against HeLa 
cells of ICNPs functionalized with the three different ligands was investigated for several 
incubation times and ICNPs concentrations ranging from 0.01 to 2 mg·mL-1 (Figure 4). 
 
Figure 4: Cytotoxicity of different [ICNPs-ligand] systems as a function of the incubation time 
and of the ICNPs concentration of the incubation media. Color code: [100-80%]: green; [80-
60%]: yellow; [60-0%]: red. 
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ICNPs functionalized by the cationic ligand DOP-TEG-C6 display an acute toxicity even for 
short incubation times. This toxicity can be attributed to the C6 hydrophobic chain carried by 
the quaternary ammonium group. In sharp contrast, the ligands DOP-TEG-COOH and DOP-
TEG-Zwitter provide ICNPs with a very good biocompatibility. No significant cytotoxicity was 
observed for incubation times up to 4 h at any of the concentrations in NPs of the incubation 
media. For 24 h incubation, the biocompatibility of ICNPs is very good up to 0.025 mg·mL-1, 
the toxicity increasing slightly for higher concentrations. These values are comparable to what 
can be observed with typical biocompatible iron oxide nanoparticles.34 Concerning iron carbide 
nanoparticles, studies are scarce, and until now limited to Fe5C2 nanoparticles. For example, 
Xie et al observed a 20% cellular death after 24 h incubation with 0.025 mg·mL-1 of 
polydisperse polymer coated Fe5C2 nanoparticles.
21 With similar nanoparticles coated with 
BSA, Hou et al evidenced the death of 10% of the cells after 24 h incubation with a NPs 
concentration of 0.025 mg·mL-1.29 The biocompatibility of our system is significantly better, 
since no cytotoxicity was evidenced when cells were incubated for 24 h with 0.025 mg·mL-1 
Fe2.2C ICNPs functionalized with DOP-TEG-COOH and Zwitter. These results clearly 
evidence the critical role played by the ligands in the final biocompatibility of the couple 
[ICNPs-Ligand]. The three systems were further characterized through a cellular uptake study. 
HeLa cells were incubated for 4 h in media containing different concentration of functionalized 
ICNPs. After incubation, the cells were washed with PBS, and subjected to ICP analysis to 
determine their iron content (Table 2). 
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Table 2. Cellular-uptake of different [ICNPs-ligand] systems as a function of the concentration 
of the incubation media (incubation time = 4 h). 
Ligand 
NPs conc. 
(mg·mL-1) 
Viability 
(%) 
ppbFe/well 
[error%] 
pgFe/cell 
[error%] 
Control experiment - 100 17 [8] 4 [9] 
DOP-TEG-C6 (IV) 
 
0.5 2 169 [34] 44 [36] 
1.0 2 349 [31] 88 [29] 
2.0 3 821 [9] 213 [8] 
DOP-TEG-COOH (II) 
 
0.5 100 9 [15] 2 [14] 
1.0 90 14 [9] 4 [8] 
2.0 86 10 [39] 2 [40] 
DOP-TEG-Zwitter (V) 
 
0.5 100 276 [2] 69 [4] 
1.0 86 551 [3] 140 [3] 
2.0 93 234 [13] 60 [12] 
 
For the ICNP-DOP-TEG-C6 system, the concentration of iron inside the cells increases with 
the increase of the concentration, evidencing the ability of this system to easily enter in the 
cells. The high cellular-uptake of ICNPs-DOP-TEG-C6 is not surprising, since NPs with 
positively charged surface interact strongly with the negatively charged surface of cells.35,36 
The ICNPs-DOP-TEG-Zwitter system displays a similar behavior, though a drop in the cellular 
uptake can be observed for the most concentrated incubation medium (2 mg·mL-1). This 
decrease is attributed to a partial aggregation and precipitation of ICNPs in the incubation 
medium at this concentration. The cellular-uptake of ICNPs functionalized by DOP-TEG-C6 
and Zwitter is in the same range than what is usually observed with conventional iron oxide 
nanoparticles.37,38 
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In strong contrast, no significant cellular uptake was observed for ICNPs functionalized by 
DOP-TEG-COOH. This result is expected since at the pH at which this study was performed 
(7.2), the ligands are under the carboxylate form (anionic). Both ICNPs surface and cells surface 
are thus negatively charged, and the repulsive electrostatic interactions between them prevent 
the penetration of the NPs in the cells. These observations prove once again that the behavior 
of nanoparticles in biological conditions is highly impacted by the ligands that are present at 
their surface. 
ICNPs functionalized with the DOP-TEG-Zwitter ligand appear as promising candidates for 
medical magnetic hyperthermia since they combine high SAR in water, low cytotoxicity and 
good cellular uptake. However, the environment in cells and tumors is known to have a higher 
viscosity than pure water, which can affect the heating properties of magnetic nanoparticles. To 
investigate the influence of the medium’s viscosity on the heating power of ICNPs, their SAR 
was measured in aqueous solutions containing different concentrations of glycerol (Figure 5). 
 
Figure 5. SAR measurement at 100 kHz for ICNPs (DOP-TEG-Zwitter ligand) dispersed in 
media with different viscosities. 
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The results show that the SAR of ICNPs is slowly decreasing when the proportion of glycerol 
is increasing, evidencing a dependence of the SAR on the solvent’s viscosity. Nevertheless, the 
SAR values remain high (exceeding 515 W/g up to 20 wt% glycerol, and 320 W/g at 50 wt% 
glycerol (47 mT, 100 kHz)), making these NPs of interest for practical applications. 
To finish, ICNPs functionalized by the DOP-TEG-Zwitter ligand were further characterized by 
high resolution TEM and STEM-HAADF-EDX at t0, and after 40 days in water (Figure 6). 
 
Figure 6. High resolution electron microscopy of ICNPs in water: at t0 after functionalization, 
and after 40 days in water. a) High Angle Annular Dark Field Scanning Electron Microscopy 
(STEM-HAADF); b) Bright field high resolution TEM; c) STEM-HAADF-EDX (Energy 
Dispersive X-ray) elemental mapping. 
The results show in both cases a core-shell structure with an oxygen rich shell and an iron rich 
core, suggesting the formation of a thin shell of iron oxide (ca. 2 nm) around the iron carbide 
core. The presence of this oxide shell already at t0 shows that the surface oxidation of ICNPs is 
very fast when they are exposed to air and water during the ligand exchange reaction. 
Interestingly, no significant difference can be observed between the ICNPs at t0 and after 40 
days in water, indicating that ICNPs can be conserved a long time in aqueous solution without 
suffering from advanced oxidation and losing their advantageous magnetic properties. In 
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addition, their ability to undergo surface oxidation suggest that they could be slowly degraded 
by liver cells, which is an important factor when considering practical in-vivo applications.39-40 
CONCLUSIONS 
In summary, we show that engineered dopamine-based ligands are suitable for the transfer of 
magnetic iron carbide nanoparticles into water. The functionalized ICNPs are highly soluble 
and stable several months in all types of aqueous media investigated (water, PB, PBS, Serum). 
Despite partial oxidation, ICNPs maintain good magnetic properties, and most importantly high 
SAR in water and water-glycerol mixtures. The nature of the ligands is a key parameter 
governing the cytotoxicity and cellular-uptake of the functionalized nanoparticles. Through 
proper choice of ligand structure we were in particular able to obtain [ICNPs-ligand] systems 
displaying very low cytotoxicity, and entering easily or not in the cells. 
The biocompatibility of these ICNPs is comparable to the best of the IONs, with their superior 
magnetic properties making them promising candidates for biomedical applications, and in 
particular medical magnetic hyperthermia.  
 
METHODS/EXPERIMENTAL 
General 
All syntheses of iron-based nanoparticles were performed under argon either by using Schlenk 
techniques or in a glove box. Mesitylene (99%), toluene (99%), and tetrahydrofuran (99%) were 
purchased from VWR Prolabo, then purified on alumina desiccant and degassed through three 
freeze-pump-thaw cycles. The commercial products, hexadecylamine (HDA, 99%) and 
palmitic acid (PA, 99%) were purchased from Sigma-Aldrich. These compounds were used 
without any additional purification. Dopamine-based ligands were synthesized following 
methods reported in the literature. Ligand exchange reactions were performed using methanol 
and dichloromethane degassed by nitrogen bubbling. 
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Characterization 
The size and the morphology of as-synthesized nanoparticles were studied by transmission 
electronic microscopy TEM. TEM grids were prepared by drop casting a colloidal solution 
containing as prepared NPs on a copper grid covered with amorphous carbon. Conventional 
bright-field images were performed using JEOL microscopes (Model 1400 and 2010) working 
at 120 kV and 200 kV respectively. HR-TEM, STEM-HAADF and EDX measurements were 
carried out using a JEOL JEM-ARM200F Cold FEG working at 200 kV. XRD measurements 
were performed on a PANalytical Empyrean diffractometer using Co-Kα radiation (λ=0.1789 
nm) at 45 kV and 40 mA. Magnetic measurements were performed on a Vibrating Sample 
Magnetometer (VSM, Quantum Device PPMS Evercool II). XRD and VSM studies were 
carried out on compact powder samples as well as on diluted assemblies that were prepared and 
sealed under argon atmosphere. DLS analyses were performed on a Malvern Zetasizer Nano 
ZS equipment ([0,3 nm – 10 µm]). Laser He-Ne 633 nm, 4 mW maxi). Synthesized organic 
ligands were characterized by 1H NMR (Bruker 400 MHz). LDI-MS were performed on a 
Bruker Autoflex III MALDI-TOF mass spectrometer equiped with a Smartbeam 2 laser and a 
MTP 384 steel target. Analysis conditions : ion source 1 = 19.00 kV, ion source 2 = 16.60 kV, 
lens voltage = 8.44 kV, reflector voltage = 20.00 kV, reflector voltage 2 = 9.69 kV, pulsed ion 
extraction time = 10 ns, suppression = 100 Da. TGA were carried out with a Mettler Toledo 
“TGA/DSC 1 STAR System”. 
Hyperthermia measurements 
For a typical hyperthermia experiment, an air-tight tube containing about 10 mg of powder of 
iron carbide or iron/iron carbide nanocrystals dispersed in 0.5 ml of mesitylene was filled under 
inert atmosphere. The tube was then placed in a calorimeter containing 2.5 ml of deionized 
water, the temperature of which was monitored during the experiment. The calorimeter was 
exposed to an alternative magnetic field for a time varying between 10 and 40 s so that the 
temperature rise never exceeded 20°C. The temperature rise at the end of the magnetic field 
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application was always measured after shaking the calorimeter to ensure the temperature 
homogeneity, which was measured by two probes (at the top and the bottom of the calorimeter). 
The temperature rise was determined after this process from the mean slope of the ΔT/Δt 
function. Then the raw SAR values were calculated using the expression: 
𝑆𝐴𝑅 =
∑ Cpimii
mFe
×
ΔT
Δt
 
where Cpi and mi are the specific heat capacity and the mass for each component respectively 
(Cp = 449 J kg-1K-1 for Fe NPs, Cp = 1750 J kg-1K-1for mesitylene, Cp = 4186 J kg-1K-1 for 
water, Cp = 2430 J kg-1K-1 for glycerol and Cp = 720 J kg-1K-1 for glass), and mFe is the mass 
of the pure iron carbide nanocristals. 
 
Synthesis of Fe(0) nanoparticles 
In a typical synthesis, the Fe(0) NPs were prepared as follows: in the glove box, 0.65 mmol of 
PA (333.2 mg) and 0.5 mmol of HDA (241.5 mg) were added to a green solution of 0.5 mmol 
{Fe[N(SiMe3)2]2}2 (376.5 mg) in 20 ml of distilled and degassed mesitylene in a Fischer Porter 
bottle. The bottle was then pressurized with dihydrogen (2 bar) and placed in an oil bath at 
150°C for 48 h under magnetic stirring (400 rpm). After 48 h, the reaction was stopped and the 
NPs were recovered by decantation assisted by a magnet, and washed 3 times (3*10 mL) with 
toluene and 3 times (3*10 mL) with THF. The NPs were then dried under vacuum. According 
to elemental analysis, the black powder obtained contains ~50 wt% of iron. The NPs were 
further characterized by XRD, VSM and TEM. 
 
Synthesis of iron carbide nanoparticles (ICNPs) 
Iron carbide NPs were obtained through the carbidization of preformed Fe(0) NPs. In a typical 
experiment, 12.5 nm Fe(0) NPs (50 mg, 0.45 mmol of iron) were dispersed in mesitylene (9 
mL), and the mixture was pressurized with CO / H2 (2 bar / 2 bar) at 150°C for 140 h. At the 
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end of the reaction, the NPs were recovered by decantation assisted by a magnet and were 
washed 3 times with toluene (3x5 mL). The NPs were then dried under vacuum. According to 
the elemental analysis, the black powder obtained contains ~70 wt% of iron. The NPs were 
further characterized by XRD, VSM and TEM. 
 
Ligand exchange reaction 
In a typical ligand exchange reaction, ICNPs were dispersed in a mixture of dichloromethane 
and methanol (5/1). The water-soluble ligand (5 mass equivalents) was added to the dispersion, 
followed by triethylamine (250 µL) addition. The mixture was stirred overnight at room 
temperature. The work up of the reaction consisted of 3 washing cycles with hexane, followed 
by redispersion in water and purification by dialysis during 48 h. The presence of the desired 
ligands at the surface of the ICNPs was confirmed by LDI/MS experiments. 
Cell viability assay 
Cell viability (HeLa cells) was measured by quantifying the reduction of a dye indicator alamar 
blue. Alamar blue is a dye that takes advantage of mitochondrial reductases to change from 
oxidized indigo blue state to reduced pink state. This dye has been successfully used in various 
cell cultures to measure cell viability. Briefly, cells in 4 well plates are loaded with 300 mL 
culture medium containing 10% alamar blue (Biosource International) and incubated in 37°C, 
5% CO2 for 2 h. 100 mL medium from each well was then transferred to a 96 well plate and 
subjected to measurement. The reduction of alamar blue was measured and calculated by a 
SpectroMax M5 micro-plate reader (Molecular Device) at 570 nm and 600 nm wavelengths. 
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Highly magnetic Fe2.2C iron carbide nanoparticles displaying excellent specific absorption rates 
were successfully stabilized in aqueous media using specific dopamine-based ligands. Even 
after several months of exposure to water and air, iron carbide nanoparticles retained high 
heating power through magnetic induction. The nature of the ligands was proven to be a critical 
parameter to tune the biocompatibility and cellular-uptake of the considered nanoparticles. 
